Literature DB >> 2750866

Growth rate of acoustic neuromas.

G E Valvassori1, M Guzman.   

Abstract

During the past 25 years the authors have diagnosed over 1,600 acoustic neuromas. In almost all of the cases surgery for the removal of the tumor was performed shortly after the diagnostic tests. However in 35 cases one or more follow-up imaging studies was performed since the patients refused surgery, or surgery was not performed because of the poor general condition of the patients or the small size of the lesion, particularly in individuals of advanced age. In the latter group there was a clear understanding that surgery would be performed if the follow-up study showed progression of the lesion. In this paper the authors review the evolution of the tumor in the 35 cases, try to establish the rate of growth in cases where the tumor became larger, and correlate tumor evolution to patient's age and clinical findings.

Entities:  

Mesh:

Year:  1989        PMID: 2750866

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  5 in total

1.  Clinical growth rate of acoustic schwannomas: correlation with the growth fraction as defined by the monoclonal antibody ki-67.

Authors:  T H Lesser; R C Janzer; P Kleihues; U Fisch
Journal:  Skull Base Surg       Date:  1991

2.  Natural history of acoustic neuromas.

Authors:  G E Valvassori; M Shannon
Journal:  Skull Base Surg       Date:  1991

3.  Conservative management of acoustic neuroma.

Authors:  Abdulrahman Al Sanosi; Paul A Fagan; Nigel D W Biggs
Journal:  Skull Base       Date:  2006-05

4.  Baseline and follow-up MRI of the internal auditory canal after suboccipital resection of acoustic schwannoma: appearances and clinical correlations.

Authors:  M Smith; M Castillo; J Campbell; H Pillsbury; T Walters
Journal:  Neuroradiology       Date:  1995-05       Impact factor: 2.804

5.  Head-and-neck paragangliomas: An overview of 54 cases operated at a tertiary care center.

Authors:  Shuchita Singh; Renu Madan; Manoj Kumar Singh; Alok Thakar; Suresh Chandra Sharma
Journal:  South Asian J Cancer       Date:  2019 Oct-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.